316 related articles for article (PubMed ID: 10869187)
21. A Novel, NADH-Dependent Acrylate Reductase in Vibrio harveyi.
Bertsova YV; Serebryakova MV; Baykov AA; Bogachev AV
Appl Environ Microbiol; 2022 Jun; 88(11):e0051922. PubMed ID: 35612301
[TBL] [Abstract][Full Text] [Related]
22. Reaction of the NAD(P)H:flavin oxidoreductase from Escherichia coli with NADPH and riboflavin: identification of intermediates.
Nivière V; Vanoni MA; Zanetti G; Fontecave M
Biochemistry; 1998 Aug; 37(34):11879-87. PubMed ID: 9718311
[TBL] [Abstract][Full Text] [Related]
23. Impeded electron transfer from a pathogenic FMN domain mutant of methionine synthase reductase and its responsiveness to flavin supplementation.
Gherasim CG; Zaman U; Raza A; Banerjee R
Biochemistry; 2008 Nov; 47(47):12515-22. PubMed ID: 18980384
[TBL] [Abstract][Full Text] [Related]
24. Probing the NADPH-binding site of Escherichia coli flavodoxin oxidoreductase.
Leadbeater C; McIver L; Campopiano DJ; Webster SP; Baxter RL; Kelly SM; Price NC; Lysek DA; Noble MA; Chapman SK; Munro AW
Biochem J; 2000 Dec; 352 Pt 2(Pt 2):257-66. PubMed ID: 11085917
[TBL] [Abstract][Full Text] [Related]
25. Initial-rate kinetics of the flavin reductase reaction catalysed by human biliverdin-IXbeta reductase (BVR-B).
Cunningham O; Gore MG; Mantle TJ
Biochem J; 2000 Jan; 345 Pt 2(Pt 2):393-9. PubMed ID: 10620517
[TBL] [Abstract][Full Text] [Related]
26. Cloning and nucleotide sequence of the gene for NADH:FMN oxidoreductase from Vibrio harveyi.
Izumoto Y; Mori T; Yamamoto K
Biochim Biophys Acta; 1994 Apr; 1185(2):243-6. PubMed ID: 8167139
[TBL] [Abstract][Full Text] [Related]
27. The flavin reductase activity of the flavoprotein component of sulfite reductase from Escherichia coli. A new model for the protein structure.
Eschenbrenner M; Covès J; Fontecave M
J Biol Chem; 1995 Sep; 270(35):20550-5. PubMed ID: 7657631
[TBL] [Abstract][Full Text] [Related]
28. Vibrio harveyi NADPH:FMN oxidoreductase: preparation and characterization of the apoenzyme and monomer-dimer equilibrium.
Liu M; Lei B; Ding Q; Lee JC; Tu SC
Arch Biochem Biophys; 1997 Jan; 337(1):89-95. PubMed ID: 8990272
[TBL] [Abstract][Full Text] [Related]
29. Engineering and characterization of a NADPH-utilizing cytochrome b5 reductase.
Marohnic CC; Bewley MC; Barber MJ
Biochemistry; 2003 Sep; 42(38):11170-82. PubMed ID: 14503867
[TBL] [Abstract][Full Text] [Related]
30. Thermodynamic analysis of the binding of oxidized and reduced FMN cofactor to Vibrio harveyi NADPH-FMN oxidoreductase FRP apoenzyme.
Li X; Chow DC; Tu SC
Biochemistry; 2006 Dec; 45(49):14781-7. PubMed ID: 17144671
[TBL] [Abstract][Full Text] [Related]
31. NAD(P)H-flavin oxidoreductase from the bioluminescent bacterium, Vibrio fischeri ATCC 7744, is a flavoprotein.
Inouye S
FEBS Lett; 1994 Jun; 347(2-3):163-8. PubMed ID: 8033996
[TBL] [Abstract][Full Text] [Related]
32. Identification of the gene encoding the major NAD(P)H-flavin oxidoreductase of the bioluminescent bacterium Vibrio fischeri ATCC 7744.
Zenno S; Saigo K; Kanoh H; Inouye S
J Bacteriol; 1994 Jun; 176(12):3536-43. PubMed ID: 8206830
[TBL] [Abstract][Full Text] [Related]
33. Four crystal structures of the 60 kDa flavoprotein monomer of the sulfite reductase indicate a disordered flavodoxin-like module.
Gruez A; Pignol D; Zeghouf M; Covès J; Fontecave M; Ferrer JL; Fontecilla-Camps JC
J Mol Biol; 2000 May; 299(1):199-212. PubMed ID: 10860732
[TBL] [Abstract][Full Text] [Related]
34. Activity coupling and complex formation between bacterial luciferase and flavin reductases.
Tu SC
Photochem Photobiol Sci; 2008 Feb; 7(2):183-8. PubMed ID: 18264585
[TBL] [Abstract][Full Text] [Related]
35. Crystal structure of NAD(P)H:flavin oxidoreductase from Escherichia coli.
Ingelman M; Ramaswamy S; Nivière V; Fontecave M; Eklund H
Biochemistry; 1999 Jun; 38(22):7040-9. PubMed ID: 10353815
[TBL] [Abstract][Full Text] [Related]
36. Conversion of NfsB, a minor Escherichia coli nitroreductase, to a flavin reductase similar in biochemical properties to FRase I, the major flavin reductase in Vibrio fischeri, by a single amino acid substitution.
Zenno S; Koike H; Tanokura M; Saigo K
J Bacteriol; 1996 Aug; 178(15):4731-3. PubMed ID: 8755909
[TBL] [Abstract][Full Text] [Related]
37. Cloning and characterization of a novel human dual flavin reductase.
Paine MJ; Garner AP; Powell D; Sibbald J; Sales M; Pratt N; Smith T; Tew DG; Wolf CR
J Biol Chem; 2000 Jan; 275(2):1471-8. PubMed ID: 10625700
[TBL] [Abstract][Full Text] [Related]
38. Structural analysis of the FMN binding domain of NADPH-cytochrome P-450 oxidoreductase by site-directed mutagenesis.
Shen AL; Porter TD; Wilson TE; Kasper CB
J Biol Chem; 1989 May; 264(13):7584-9. PubMed ID: 2708380
[TBL] [Abstract][Full Text] [Related]
39. NADPH-cytochrome P-450 reductase. Physical properties and redox behavior in the absence of the FAD moiety.
Kurzban GP; Howarth J; Palmer G; Strobel HW
J Biol Chem; 1990 Jul; 265(21):12272-9. PubMed ID: 2115516
[TBL] [Abstract][Full Text] [Related]
40. Reduced flavin: donor and acceptor enzymes and mechanisms of channeling.
Tu SC
Antioxid Redox Signal; 2001 Oct; 3(5):881-97. PubMed ID: 11761334
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
